Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States. It focuses on adults with tardive dyskinesia who remain symptomatic while receiving or after stopping a VMAT2 inhibitor.
In United States
This study is recruiting in the United States. It focuses on ADHD.
In United StatesThis study is recruiting in the United States, in France, in Argentina, .... It is testing KarXT for manic episodes in bipolarity type I, including participants taking lithium, valproate, or lamotrigine.
In United StatesThis study is recruiting in the United States, in Brazil, in Hungary, .... It is testing esketamine for depression.
In United StatesThis study is recruiting in the United States, in Australia, in New Zealand, .... It is testing KarXT for manic episodes in bipolarity type I.
In United StatesThis study is recruiting in the United States, in Croatia, in India, .... It is testing KarXT for manic episodes in bipolarity type I.
In United StatesThis study is recruiting in the United States, in Argentina, in Colombia, .... It is testing KarXT for schizophrenia.
In United StatesThis study is recruiting in the United States, in Bulgaria, in Czech Republic, .... It is testing SPT-300 (GlyphAllo) for depression.
In United StatesThis study is recruiting in the United States. It is testing Efficacy of AXS-05 Compared to Bupropion for depression.
In United StatesThis study is recruiting in the United States, in France, in Canada, .... It is testing KarXT and KarX-EC for schizophrenia.
In United StatesThis study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.
In United StatesThis study is recruiting in the United States. It focuses on Schizophrenia.
In United States